36 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) jumped 65% to $0.6382.
83 Biggest Movers From Yesterday
Gainers
Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly traded company.
The Daily Biotech Pulse: FDA Adcomm Backing For Novavax’s COVID-19 Shot, New Data On Moderna’s Omicron Vaccine, DBV Tech’s Encouraging Peanut Allergy Trial Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
DBV Technologies’ Shares Shoot Higher As Positive Results From Late-Stage Study Of Peanut Allergy In Toddlers Met Primary Endpoint
DBV Technologies (NASDAQ: DBVT) announced positive topline results from EPITOPE study of its drug candidate Viaskin Peanut 250 µg for the treatment of peanut-allergic toddlers ages 1 to 3 years.
Dbv Technologies Announces Topline Results From Phase 3 EPITOPE Trial Of Viaskin Peanut In Peanut- Allergic Toddlers
https://docs.publicnow.com/viewDoc?hash_primary=DDA480833CDBAE49CB8CC1FA7E44E236C2CEEF72
68 Biggest Movers From Friday
Gainers
Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 101.8% to close at $40.77 on Friday after jumping 39% on Thursday.
Mid-Afternoon Market Update: Crude Oil Rises Over 6%; VIZIO Shares Slide
U.S. stocks remained lower toward the end of trading, with the Nasdaq dropping over 200 points on Friday.
Mid-Day Market Update: Dow Dips 300 Points; Sweetgreen Shares Spike Higher
U.S. stocks remained lower midway through trading, with the Dow Jones tumbling 300 points on Friday.
43 Stocks Moving In Friday’s Mid-Day Session
Gainers
VEON Ltd. (NASDAQ: VEON) rose 45.6% to $0.3830 after dropping 41% on Thursday.
24 Stocks Moving in Friday’s Pre-Market Session
Gainers
Statera Biopharma, Inc. (NASDAQ: STAB) rose 30.4% to $0.9520 in pre-market trading. Statera Biopharma recently submitted Phase 1 clinical trial protocol to the FDA for investigational treatment of long-haul COVID-19.